Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Thoracoscopic-Guided Thoracic Paravertebral Block: 15 mL of 0.375% ropivacaine injected under thoracoscopic vision into
the paravertebral space (approx. T5 level, ~0.5 cm below parietal
total 15 mL) under thoracoscopic vision.
Sponsors
Sahil Ahmed Mansuri
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients eighteen years and above undergoing VATS ASA Grade one to three Willing to give informed consent
Exclusion criteria
Exclusion criteria: 1. Coagulopathy or on anticoagulants 2. Allergy to local anesthetic 3. Conversion to open thoracotomy 4. Re-operation within 48 hours 5. Patient refusal or inability to understand pain scoring
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome of this study will be postoperative pain intensity assessed by the Visual Analogue Scale (VAS, 0 10) at 2, 24, and 48 hours after surgery, both at rest and during coughing.Timepoint: The primary outcome of this study will be postoperative pain intensity assessed by the Visual Analogue Scale (VAS, 0 10) at 2, 24, and 48 hours after surgery, both at rest and during coughing. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcomes will include: Time required to perform the nerve block,incidence of adverse events such as post operative nausea, vomiting, & puncture-site bleeding within 48 hoursTimepoint: at 2, 24 & 48 hours | — |
Countries
India
Contacts
Public ContactDr Ramkaran Chaudhary
AIIMS Jodhpur
Outcome results
None listed